Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07322172 · ClinicalTrials.gov registry record · NA

Pilot Study of Patient Navigation for Kidney Stone Patients After ED Visits

A NA study, sponsored by University of California, San Francisco.

Not yet
Registry status
NA
Development phase
31
Enrollment target

NCT07322172 is a NA study that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 31 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07322172, a NA study, has not yet begun recruiting, sponsored by University of California, San Francisco.

NOT YET RECRUITING
Registry status
NA
Development phase
31 participants
Enrollment target

Study Summary

Patients who visit the emergency department for kidney stones are sometimes referred to urology for follow-up care but never complete that visit. Missing follow-up appointments can lead to worse outcomes, including recurrent pain, infection, or surgery. Research shows that patients who are socially or economically at risk (such as those with public insurance, lower income, or limited English proficiency) are more likely to experience these care gaps. This study will pilot a patient navigation program designed to help patients with urinary stone disease (USD) attend their scheduled urology appointments after being seen in the Emergency Department. Using an electronic health record (EHR) based prediction model developed in earlier research, patients at higher risk for being lost to follow-up will be identified and invited to participate. Each participant will be paired with a trained patient navigator who will assess barriers to care, provide support, and maintain contact for about 12 weeks. The goal of this study is to evaluate the outcomes and feasibility of this navigation intervention. Findings will help determine whether a larger study should test if this approach improves access to care and health outcomes for patients with kidney stones.

Interventions

  • OTHER Patient Navigation

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2026-07
Est. Completion 2026-07
Phase NA

What the Registry Record Tells You About NCT07322172

The ClinicalTrials.gov registry entry for NCT07322172 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Patient Navigation is the first listed.

NCT07322172 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07322172 about?

NCT07322172 is a clinical study titled "Pilot Study of Patient Navigation for Kidney Stone Patients After ED Visits". Patients who visit the emergency department for kidney stones are sometimes referred to urology for follow-up care but never complete that visit. Missing follow-up appointments can lead to worse outcomes, including recurrent pain, infection, or surgery. Research shows that patients who are socially ...

What is the current status of trial NCT07322172?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 31 participants. The study started on 2026-07. Estimated completion is 2026-07.

What interventions are being tested in trial NCT07322172?

The interventions under investigation include: Patient Navigation (OTHER).

Who is sponsoring clinical trial NCT07322172?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.